ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,088 | +3563.2% | 101,928 | +2911.2% | 0.00% | – |
| Q1 2023 | $57 | -99.0% | 3,385 | +648.9% | 0.00% | – |
| Q2 2022 | $6,000 | -89.8% | 452 | -66.5% | 0.00% | – |
| Q1 2021 | $59,000 | +247.1% | 1,350 | +321.9% | 0.00% | – |
| Q4 2020 | $17,000 | -93.2% | 320 | -97.1% | 0.00% | – |
| Q3 2020 | $251,000 | +33.5% | 11,021 | +22.7% | 0.00% | – |
| Q2 2020 | $188,000 | +45.7% | 8,985 | -3.3% | 0.00% | – |
| Q1 2020 | $129,000 | +1742.9% | 9,294 | +1733.1% | 0.00% | – |
| Q2 2019 | $7,000 | -93.6% | 507 | -88.7% | 0.00% | – |
| Q3 2018 | $110,000 | +168.3% | 4,497 | +114.3% | 0.00% | – |
| Q2 2018 | $41,000 | – | 2,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |